OUR STORY

Research, Tech Innovation and Education together.

The D’Or Institute for Research and Education (IDOR) is a private and nonprofit organization whose aim is to promote scientific research and technological progress in healthcare and excellence in education.

The institute was founded in 2010 by the physicians Jorge Moll Neto and Fernanda Tovar-Moll. Its modern headquarters is located in Botafogo, Rio de Janeiro. IDOR has facilities and state-of-the-art equipment for scientific research and it is also partially supported by the Rede D’Or São Luiz hospitals group, its main sponsor. IDOR also coordinates activities of education and innovation from the Rede D’Or São Luiz, creating opportunities for the interaction between other academic and technological institutions.

IDOR believes in the importance of investing in education and the training of healthcare professionals. We offer specialization courses, professional training and academic internships, as well as medical residency programs approved by the Ministry of Education and Culture (MEC).

Our research effort stands out due to the quality and productivity of our science team, and to our modern infrastructure, which enables several research initiatives, especially in the fields of Neurosciences, Intensive Medicine, Internal Medicine, Pediatrics and Oncology.

Our mission

To be a research and education institution of excellence, offering unique products and services in healthcare and biotechnology.

Our goals

To be recognized nationally and internationally as an innovative private institution of research and education in healthcare.

INFRASTRUCTURE

IDOR has a modern headquarters with laboratory infrastructure, as well as access to a technological park, imaging equipment and infrastructure from  32 hospitals of D’Or São Luiz Network and 35 oncology clinics recently acquired by the group.

In 2014, we opened an advanced Molecular Biology and Cellular Reprogramming Laboratory, a $7-million investment. With over 250 m² of grounds and equipped through a partnership with BNDES and Finep, it includes cellular culture and molecular biology rooms, a robotic system for pharmaceutical screening, and an area for cellular therapy clinical essays.

Our high-technology equipment allows us to analyze the effect of drugs in lab-grown human tissue and to observe in detail, and in an automated way, molecular and cellular alterations. Our infrastructure, allied to our skilled team, lets us identify the biological and therapeutical potential of drugs, contributing to the pipeline of new medicine discovery.

Currently, IDOR’s laboratory is the only one in Latin America able to produce reprogrammed stem cells from urine, a non-invasive and practical method.

More recently, in 2016, alongside RDSL, IDOR modernised its Neuromodulation Laboratory. Equipped with electroencephalogram (EEG) systems, Transcranial Magnetic Stimulation (TMS), repetitive TMS (rTMS),

Transcranial Stimulation Direct Current (tDCS), neuronavigation, among other technologies for the development of multidisciplinary research, relies now on next-generation 3-tesla magnetic resonance imaging (MRI), which represents the state-of-the-art technology, considered the most modern equipment ever produced within this
category.

 Integrated to these tools is the Image Processing Laboratory, which has servers dedicated to process, analyze, store and backup images, graphic processors with GPU technology (Graphics Processing Unit), besides several high performance work stations with remote access. The lab allows the development of sophisticated statistical algorithms, pattern recognition and multivariate analyses, facilitating the integration with multiple systems, brain-machine interfaces and virtual reality equipment.

 Another special feature is a processing and neurofeedback tool developed by IDOR, the FRIEND - Functional Real-time Endogenous Neuromodulation and Decoding, which integrates data from functional magnetic resonance and virtual reality scenarios. The tool is being used globally in diverse high-impact research centers.